Torque: Torque Therapeutics Announces the Appointment of John Cox as Chief Executive Officer

Torque Therapeutics: Torque Presents New Preclinical Data for its Deep-Primed Cellular Immunotherapy Programs at the American Association for Cancer Research (AACR) Annual Meeting

Torque Therapeutics: Torque begins phase 1 trial of TRQ─1501 Deep IL─15 Primed T Cells in patients with advanced solid tumors and lymphomas

Torque Therapeutics: Thermo Fisher, Torque Build Dedicated Slipstream Mfg. Facility

Press Release: Torque Therapeutics : Torque Announces Appointment of Immunotherapy Pioneer F. Stephen Hodi, MD, to Scientific Advisory Board and Alex Bruni as COO/ CFO

Torque Therapeutics: Torque Announces the Presentation of Preclinical Data for Deep IL-15 Primed T Cells Demonstrating Superior T Cell Expansion, Persistence, and Safety Compared with Systemically Administered IL-15

Torque Therapeutics: Torque Announces Proprietary Slipstream Platform for High-Efficiency Manufacturing of Deep-Primed T-Cell Therapies